Resolvin E1 promotes resolution of inflammation in a mouse model of an acute exacerbation of allergic asthma - PubMed (original) (raw)
. 2014 Jun;126(11):805-14.
doi: 10.1042/CS20130623.
Affiliations
- PMID: 24344649
- DOI: 10.1042/CS20130623
Resolvin E1 promotes resolution of inflammation in a mouse model of an acute exacerbation of allergic asthma
Rylie P Flesher et al. Clin Sci (Lond). 2014 Jun.
Abstract
Endogenous mediators, such as RvE1 (resolvin E1), promote resolution of an inflammatory response and have potential as novel therapeutic agents. In the present study, we investigated the activity of RvE1 in a model of an acute exacerbation of chronic allergic asthma in mice. Animals sensitized to OVA (ovalbumin) received controlled low-level challenge with aerosolized antigen for 4 weeks, followed by a single moderate-level challenge to simulate an allergen-induced exacerbation of asthmatic inflammation. Induction of an exacerbation was associated with rapid recruitment of neutrophils, lymphocytes and eosinophils, together with increased levels of Th2 and pro-inflammatory cytokines. When administered before the final moderate-level challenge, RvE1 had only a modest effect on airway inflammation. To assess its effects when administered after induction of an exacerbation, we first characterized the cellular and molecular events associated with spontaneous resolution of airway inflammation over the following 96 h. Subsequently, we showed that administration of RvE1 at 2 and 8 h after the final challenge accelerated this process significantly. Specifically, RvE1 promoted a decline in the number of inflammatory cells, concentration of cytokines in lavage fluid and expression of mRNA for cytokines by macrophages, confirming its pro-resolution activity. In vitro, RvE1 had no apparent effect on lymphocytes, but suppressed significantly cytokine production by pulmonary macrophages, with evidence of down-regulation of the nuclear translocation of NF-κB (nuclear factor κB) p65 in these cells. The present study provides novel evidence that RvE1 can facilitate resolution of airway inflammation in a clinically relevant model of an acute exacerbation of asthma, possibly via its effects on activated pulmonary macrophages.
Similar articles
- Protective effect of resolvin E1 on the development of asthmatic airway inflammation.
Aoki H, Hisada T, Ishizuka T, Utsugi M, Ono A, Koga Y, Sunaga N, Nakakura T, Okajima F, Dobashi K, Mori M. Aoki H, et al. Biochem Biophys Res Commun. 2010 Sep 10;400(1):128-33. doi: 10.1016/j.bbrc.2010.08.025. Epub 2010 Aug 12. Biochem Biophys Res Commun. 2010. PMID: 20708601 - Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma.
Aoki H, Hisada T, Ishizuka T, Utsugi M, Kawata T, Shimizu Y, Okajima F, Dobashi K, Mori M. Aoki H, et al. Biochem Biophys Res Commun. 2008 Mar 7;367(2):509-15. doi: 10.1016/j.bbrc.2008.01.012. Epub 2008 Jan 9. Biochem Biophys Res Commun. 2008. PMID: 18190790 - Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
Kim SH, Hong JH, Lee YC. Kim SH, et al. Eur J Pharmacol. 2013 Feb 15;701(1-3):131-43. doi: 10.1016/j.ejphar.2012.11.033. Epub 2012 Nov 28. Eur J Pharmacol. 2013. PMID: 23201068 - Resolvin E1 as a novel agent for the treatment of asthma.
Hisada T, Ishizuka T, Aoki H, Mori M. Hisada T, et al. Expert Opin Ther Targets. 2009 May;13(5):513-22. doi: 10.1517/14728220902865622. Expert Opin Ther Targets. 2009. PMID: 19368495 Review. - The role of polyunsaturated ω-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation.
Gyurko R, Van Dyke TE. Gyurko R, et al. Crit Rev Immunol. 2014;34(4):347-57. doi: 10.1615/critrevimmunol.2014009982. Crit Rev Immunol. 2014. PMID: 24941160 Free PMC article. Review.
Cited by
- Endogenous inhibitory mechanisms in asthma.
Chiarella SE, Barnes PJ. Chiarella SE, et al. J Allergy Clin Immunol Glob. 2023 Jul 5;2(4):100135. doi: 10.1016/j.jacig.2023.100135. eCollection 2023 Nov. J Allergy Clin Immunol Glob. 2023. PMID: 37781649 Free PMC article. Review. - Gestational exposure to titanium dioxide, diesel exhaust, and concentrated urban air particles affects levels of specialized pro-resolving mediators in response to allergen in asthma-susceptible neonate lungs.
Kumar M, Yano N, Fedulov AV. Kumar M, et al. J Toxicol Environ Health A. 2022 Mar 19;85(6):243-261. doi: 10.1080/15287394.2021.2000906. Epub 2021 Nov 21. J Toxicol Environ Health A. 2022. PMID: 34802391 Free PMC article. - n-3 Polyunsaturated Fatty Acids Modulate LPS-Induced ARDS and the Lung-Brain Axis of Communication in Wild-Type versus Fat-1 Mice Genetically Modified for Leukotriene B4 Receptor 1 or Chemerin Receptor 23 Knockout.
Hernandez J, Schäffer J, Herden C, Pflieger FJ, Reiche S, Körber S, Kitagawa H, Welter J, Michels S, Culmsee C, Bier J, Sommer N, Kang JX, Mayer K, Hecker M, Rummel C. Hernandez J, et al. Int J Mol Sci. 2023 Aug 31;24(17):13524. doi: 10.3390/ijms241713524. Int J Mol Sci. 2023. PMID: 37686333 Free PMC article. - Resolvin E1 in Follicular Fluid Acts as a Potential Biomarker and Improves Oocyte Developmental Competence by Optimizing Cumulus Cells.
Zhang Y, Zhu Z, Li H, Zhu M, Peng X, Xin A, Qu R, He W, Fu J, Sun X. Zhang Y, et al. Front Endocrinol (Lausanne). 2020 Apr 16;11:210. doi: 10.3389/fendo.2020.00210. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32373069 Free PMC article. - Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins.
Chamani S, Bianconi V, Tasbandi A, Pirro M, Barreto GE, Jamialahmadi T, Sahebkar A. Chamani S, et al. Mediators Inflamm. 2020 Mar 25;2020:3267172. doi: 10.1155/2020/3267172. eCollection 2020. Mediators Inflamm. 2020. PMID: 32308554 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical